DESSX
Price
$24.30
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
VSMPX
Price
$257.59
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

DESSX vs VSMPX

Header iconDESSX vs VSMPX Comparison
Open Charts DESSX vs VSMPXBanner chart's image
DWS ESG Core Equity S
Price$24.30
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Pls
Price$257.59
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DESSX vs VSMPX Comparison Chart
Loading...
VS
DESSX vs. VSMPX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DESSX is a Buy and VSMPX is a Buy.

FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.72T vs. DESSX (244M). VSMPX pays higher dividends than DESSX: VSMPX (1.36) vs DESSX (0.85). DESSX was incepted earlier than VSMPX: DESSX (19 years) vs VSMPX (9 years). DESSX is a more actively managed with annual turnover of: 11.00 vs. VSMPX (2.00). DESSX has a lower initial minimum investment than VSMPX: DESSX (2500) vs VSMPX (100000000). DESSX (27.10) and VSMPX (25.90) have marching annual gain over last year. VSMPX return over 5 years is better than : 83.02 vs. DESSX (67.42).
DESSXVSMPXDESSX / VSMPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years9 years-
Gain YTD19.90016.929118%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets244M1.72T0%
Annual Yield % from dividends0.851.3662%
Returns for 1 year27.1025.90105%
Returns for 3 years15.7121.3674%
Returns for 5 years67.4283.0281%
Returns for 10 years46.97N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAPMF218.958.55
+4.06%
Capgemini SE
VXTRF0.08N/A
+2.80%
VOXTUR ANALYTICS CORP.
AAVMY18.10-0.13
-0.71%
Abn Amro BK N V
UOLGY17.32-0.18
-1.03%
UOL Group Ltd.
OVID1.06-0.06
-5.36%
Ovid Therapeutics